期刊文献+

局部复发性食管癌三维适形放疗联合化疗的临床研究

A Clinical Study of Three Dimensional Conformal Radiotherapy Combined with Chemotherapy for Recurrent Esophageal Carcinoma After Radical Radiotherapy
下载PDF
导出
摘要 目的观察放疗后复发食管癌患者适形放疗联合化疗的疗效。方法2002年6月—2004年12月对76名患者采用适形放疗联合化疗。结果CR 45例(59.2%),PR 23例(30.2%),SD 4例(5.3%),PD 4例(5.3%)。1、2年生存率分别为60.5%、34.2%。死亡原因为局部失败24例(42.9%),远处转移25例(44.6%)。结论对食管癌放疗后复发患者采用适形放疗联合化疗,提高了局控率,有望提高生存率。 Objective To investigate the effects of three dimensional conformal radiotherapy (3-DCRT) combined with chemotherapy in recurrent esophageal carcinoma after radical radiotherapy. Methods From June 2002 to December 2004,76 patients were given 3-DCRT combined with chemotherapy, Results The overall response was 89.5% with CR in 45 patients ( 59, 2% ), PR in 23 patients ( 30.2% ), SD and PD in 4 patients( 5.3% ). The 1-,2-year survival rates were 60.5% (46/76) , 34, 2% (26/76) respectively. Conclusions In patients with recurrent esophageal carcinoma after radical radiotherapy, 3-DCRT combined with chemotherapy had resulted in promising local control, can increase survival rate.
出处 《肿瘤基础与临床》 2007年第6期522-523,共2页 journal of basic and clinical oncology
关键词 食管癌 三维适形放射疗法 化学疗法 esophageal carcinoma three dimensional conformal radiotherapy radiotherapy chemotherapy
  • 相关文献

参考文献6

二级参考文献44

  • 1殷蔚伯 张力军 等.放射治疗食管癌3798例临床分析[J].中华肿瘤杂志,1980,2:216-216.
  • 2[1]Oesophageal Medical Research Council Oesophageal Cancer Working Party.Surgical resection with or without preoperative chemotherapy in oesophageal cancer:A randomized controlled trial.Lancert,2002,359:1727
  • 3[2]Cunningham D,Allum WH,Stenning SP,et al.Perioperative chemotherapy in operable gastric and lower esophageal cancer final results of a randomized,controlled trial (the MAGIC trial ISRCTN 93793971).Proc Am Soc Clin Oncol,2005,23:4001
  • 4[3]Urshel JD,Vasan H,Blewett CJ.A Meta-analysis of randomized conrolled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for respectable esophageal cancer.Am J Surg,2002,183:274
  • 5[4]Malthaner R,Fenlon D.Preoperative chemotherapy for respectable thoracic esophageal cancer.The Cochrane Database of Systemic Reviews,2003,Issue 4.Art No.CD001556
  • 6[5]Urba SG,Orringer MB,TurrisiA,et al.Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.J Clin Oncol,2001,19:305
  • 7[6]Burmeister BH,Smithers BM,Fitzgerald L,et al.Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:A randomised controlled phase Ⅲ trial.Lancet Oncol,2005,6 (9):659
  • 8[7]Krasna M,Tepper J E,Niedzwiecki D.Trimodality therapy is superior to surgery alone in esophageal cancer:Results of CALGB 9781.Gastrointestinal Cancers Symposium,2006
  • 9[8]Urshel JD,Vasan H.A Mera-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for respectable esophageal cancer.Am J Surg,2003,185:538
  • 10[9]Zemanova M,Pazdro A,Novak F,et al.Prospective nonrandomized study of concurrent radiation and platinum plus 5 -FU based chemotherapy with or without paclitaxel with consecutive surgery in esophageal cancer patients.Proc Am Soc Clin Oncol,2005,23:4081

共引文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部